Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 22nd, 2019 |
Namibia Scaling up Access For Expanded Voluntary Medical Male Circumcision Services (SAFE) Activity |
South Africa USAID Pretoria |
February 21st, 2019 |
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 30th, 2020 |
FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries |
Naval Supply Systems Command |
February 14th, 2019 |
Research to Enhance the US Vision and Eye Health Surveillance System |
Centers for Disease Control and Prevention ERA |
January 31st, 2020 |
Medical Monitoring Project (MMP) |
Centers for Disease Control NCHHSTP |
May 30th, 2019 |
NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed) |
National Institutes of Health |
May 21st, 2021 |
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) |
National Institutes of Health |
July 30th, 2020 |
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) |
National Institutes of Health |
April 24th, 2019 |
Systems-level Approach to Improving Health Outcomes for HIV-positive State Prison Inmates Released to the Community |
Centers for Disease Control NCHHSTP |
February 13th, 2019 |
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional) |
National Institutes of Health |
November 4th, 2020 |
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
November 9th, 2021 |
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) |
National Institutes of Health |
November 9th, 2021 |
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional) |
National Institutes of Health |
May 8th, 2019 |
Preventing Maternal Deaths: Supporting Maternal Mortality Review Committees |
Centers for Disease Control NCCDPHP |
April 16th, 2019 |
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) |
National Institutes of Health |
March 4th, 2019 |
Advanced Nursing Education Nurse Practitioner Residency (ANE-NPR) Program |
Health Resources and Services Administration |
March 13th, 2019 |
HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
February 8th, 2019 |
HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional) |
National Institutes of Health |
February 28th, 2019 |
HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
April 1st, 2019 |
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required) |
National Institutes of Health |
|
March 13th, 2019 |
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 8th, 2019 |
HEAL Initiative: Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
February 27th, 2019 |
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
February 27th, 2019 |
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed) |
National Institutes of Health |
February 27th, 2019 |
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional) |
National Institutes of Health |
March 27th, 2019 |
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
February 27th, 2019 |
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) |
National Institutes of Health |
February 8th, 2019 |
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) |
National Institutes of Health |
March 15th, 2019 |
Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
February 21st, 2021 |
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2021 |
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2019 |
HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
February 28th, 2019 |
HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
March 6th, 2019 |
HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed) |
National Institutes of Health |
February 21st, 2021 |
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
March 27th, 2019 |
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center (U01 Clinical Trial Required) |
National Institutes of Health |
February 27th, 2019 |
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional) |
National Institutes of Health |
September 8th, 2021 |
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) |
National Institutes of Health |
September 8th, 2021 |
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
March 15th, 2019 |
HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders |
National Institutes of Health |